Processa Pharmaceuticals, Inc. (PCSA) — DEF 14A Filings
All DEF 14A filings from Processa Pharmaceuticals, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Processa Seeks 900% Share Increase, Reverse Split to Bolster Capital
— Aug 13, 2025 Risk: high
Processa Pharmaceuticals, Inc. (PCSA) is seeking stockholder approval for several critical proposals at a Special Meeting on September 2, 2025. The company prop -
Processa Pharma Files DEF 14A, Details Exec Pay
— May 12, 2025 Risk: medium
Processa Pharmaceuticals, Inc. filed a DEF 14A on May 12, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31 -
Processa Pharmaceuticals Announces 2024 Annual Meeting of Stockholders on June 28
— Apr 29, 2024 Risk: low
Processa Pharmaceuticals, Inc. (PCSA) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Stockholders for Processa Pha
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX